POP2 should have greater efficacy and fewer side effects as it is a naturally occurring NF-kB specific inhibitor.

About

 

DESCRIPTION:

Researchers at the University of South Florida have discovered a novel human gene, termed POP2 (Pyrin-Only Protein-2), has been shown to be a strong inhibitor of the Nuclear Factor kB (NFkB) protein.

NF-kB is involved in a large number of diseases including:


Rheumatoid Arthritis
Leukaemia/Cancer
AIDS Dementia Complex
Diabetes
Hodgkin’s Disease


The causes and symptoms of these and many other diseases are driven by inflammation and immune responses, in which NF-kB plays a strong regulating role. NF-kB also influences cell proliferation, apoptosis (programmed cell death), and the production of cytokines (immune response proteins). NF-kB is the most influential genetic regulator in AIDS, rheumatoid arthritis, and hematogenic cancer cell metastasis. Many of these diseases are currently being treated by modulating the activity of the NF-kB protein using synthetic drugs. POP2 should have greater efficacy and fewer side effects as it is a naturally occurring NF-kB specific inhibitor. POP2’s ability to inhibit NF-kB extends to preventing even the most influential known stimulator, Tumour Necrosis Factor (TNF), from activating NF-kB.

ADVANTAGES:


Allows modulation of NF-kB activity
Alternative to NSAIDs and corticosteroids
POP2 is a naturally occurring human protein with the ability to modulate NF-kB’s activity
Human Gene Product Can Help Treat Inflammation and Immunity Related Diseases
 

Purchase a license for full unlimited access to all innovation profiles on LEO

  • Direct connection to thousands of more innovations
  • Access to market Experts and Universities
  • Filter relevant solutions into your own dedicated Network